🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 33 of 200 · A–Z by INN

  1. carmellose sodium

    EVOLVE CARMELLOSE

    TGA: approved

  2. carmustine

    GLIADEL Eisai Co.,

    INTRACRANIAL FDA: approved · EMA: approved · TGA: approved

    L01AD01

  3. carphenazine maleate

    PROKETAZINE

    ORAL FDA: approved

  4. carprofen

    RIMADYL

    ORAL FDA: approved

  5. carrellizumab

    NMPA: clinical trials

  6. cart

    NMPA: clinical trials

  7. carteolol hydrochloride

    CARTEOLOL HYDROCHLORIDE

    OPHTHALMIC FDA: approved

  8. carteolol hydrochloride/ latanoprost

    MIKELUNA

    PMDA: approved

  9. carvedilol

    APO-CARVEDILOL Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved · PMDA: approved

  10. carvedilol phosphate

    COREG CR

    ORAL FDA: approved

  11. casimersen

    AMONDYS 45 Sarepta Therapeutics

    INTRAVENOUS FDA: approved

  12. casirivimab

    RONAPREVE

    EMA: withdrawn

    J06BD07

  13. casirivimab and imdevimab

    RONAPREVE (NOTE 2) INITIAL APPROVAL

    PMDA: approved

  14. casopitant

    ZUNRISA

    EMA: application withdrawn

  15. caspofungin

    CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD)

    EMA: approved · NMPA: clinical trials

    J02AX04

  16. caspofungin acetate

    CANCIDAS

    INTRAVENOUS FDA: approved

  17. castor oil (use as additive only)

    NULL

    TGA: approved

  18. catridecacog

    NOVOTHIRTEEN

    EMA: approved · PMDA: approved

    B02BD11

  19. catumaxomab

    KORJUNY

    EMA: approved

    L01FX03

  20. cbp-

    NMPA: clinical trials

  21. cddp-group

    NMPA: clinical trials

  22. cedazuridine

    INAQOVI

    ORAL FDA: approved · EMA: approved

    L01BC58

  23. cediranib maleate

    ZEMFIRZA

    EMA: application withdrawn

    L01XE32

  24. cefaclor

    CECLOR Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources